FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction
Condition: Small Cell Lung Carcinoma Interventions: Dietary Supplement: Cyclic, 5-day calorie restriction; Drug: Atezolizumab Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; IFOM, The FIRC Institute of Molecular Oncology; University of Milan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Diets | Immunotherapy | Nutrition | Research | Small Cell Lung Cancer